On August 23, 2017 the Board authorized the issuance of 30,000 shares of restricted common stock to a consultant for services rendered beyond the date of such consultant’s agreement with the Company to perform certain services. This issuance was in addition to the 30,000 shares of restricted common stock the consultant received to the terms of his consulting agreement dated June 8, 2017. The price per share was $0.09, which was the closing price of the Company’s stock on August 23, 2017.

On September 26, 2017, the Board authorized the issuance of 25,000 restricted shares of common stock as consideration for an extension of the Debt Agreement. The aggregate principal amount together with interest accrued thereon and applicable fees owed to the Debt Agreement is $60,000. The price per share was $0.078, which was the closing price of the Company’s stock on September 26, 2017.

On September 26, 2017 the Board awarded 200,000 shares of restricted common stock as consideration for consulting services to a consultant who was instrumental in hiring the Company’s new President and Chief Executive Officer. The price per share was $0.078, which was the closing price of the Company’s stock on September 26, 2017.

On September 26, 2017 the Board awarded 200,000 shares of restricted common stock to each of its two directors as consideration for their efforts to manage the day to day activities of the Company since January 2017. The price per share was $0.078, which was the closing price of the Company’s stock on September 26, 2017.

On September 26, 2017 the Board issued 987,000 shares of restricted common stock to a stockholder in consideration for repayment for approximately $78,000 of expenses accrued since January 2017 related to general Company expenses. The price per share was $0.078, which is the closing price of the Company’s stock on September 26, 2017. The foregoing issuances cover, in full, all expenses owed to the stockholder through July 31, 2017. At the request of the stockholder the shares of common stock will be issued to non-affiliated third parties.

As a result of the foregoing issuances, as of the date of this filing, there are currently 19,605,874 shares of common stock outstanding, and no shares of preferred stock outstanding.

Each of the foregoing issuance of securities was deemed to be exempt from the registration requirements of the Securities Act of 1933, as amended, by virtue of Section4(a)(2)thereof as a transaction by an issuer not involving a public offering.